The link between targeted nutrients and energy production
Fatigue can be a drain on one’s life, and many people suffer from it on a daily basis. Fatigue is often described by patients as a lack of energy, mental or physical tiredness, diminished endurance, and the need for prolonged recovery after physical activity.,
Of course, fatigue is common after a bout of strenuous exercise, and in people who don’t get enough sleep. This type of fatigue usually resolves after sufficient rest.
However, fatigue that goes on for a long time is not normal. Persistent fatigue can result from nutrient deficiencies, stress, inflammation, menopause, and other hormonal changes., If you often feel tired, despite getting a full night’s sleep, it may be time to consider the cause.
Fatigue is a byproduct of nearly every disease process, including viral and bacterial infections., For example, Lyme disease – an infection caused by a tick bite – is notorious for its association with fatigue, along with joint and muscle pain.,
Fortunately, scientists are beginning to get a handle on fatigue by studying mitochondria, the energy powerhouses within cells. The mitochondria are responsible for producing adenosine triphosphate (ATP), a molecule that contains high-energy bonds for use in biochemical reactions throughout the body.
While all these nutrients can be found in food, their levels in tissues tend to decline as energy demands go up. Growing evidence suggests that supplementation with one or more of these nutrients may help boost mitochondrial efficiency and reduce fatigue.
The link between mitochondrial function and chronic fatigue
Supplementation can increase ATP levels, reduce fatigue, and even improve one’s overall quality of life.
Much of the evidence comes from studies of chronic fatigue syndrome (CFS), a condition characterized by severe fatigue lasting longer than six months that is not relieved by sleep., The symptoms of CFS also include pain, mental fogginess, and insomnia. The clinical diagnosis of CFS can be made only if other disease processes have been ruled out.
A biochemical evaluation of 138 patients with CFS revealed that the subjects all had measurable dysfunctions in one or more mitochondrial pathways. Additional studies have shown that patients with CFS have deficient ATP production.,, As a result, cells from CFS patients are unable to fulfill their cellular energy needs, especially during periods of high metabolic demand such as exercise.
Since the mitochondria depend on multiple vitamins, minerals and antioxidants to operate these pathways, researchers have begun looking at mitochondrial nutrients to evaluate their effects on energy production.,
A variety of studies have indicated that supplementation can increase ATP levels, reduce fatigue and even improve one’s overall quality of life. Very interesting results have been obtained with Coenzyme Q10, NADH, L-carnitine, magnesium, and pyridoxal phosphate (vitamin B6), as discussed below.
People suffering from fatigue are often found to have low serum CoQ10 levels.
Coenzyme Q10 (CoQ10) has bioenergetic and antioxidant properties that keep the mitochondria running smoothly., CoQ10 is also known by its scientific names: ubiquinone, ubidecarenone, or ubiquinol.
The main function of CoQ10 is to transfer electrons along the mitochondrial electron transport chain, culminating in the formation of ATP. Because of its essential role, CoQ10 deficiencies impair energy production in the heart, muscles, and brain.,,
In the general population, CoQ10 deficiencies can occur as a result of environmental toxins, poor diet, oxidative stress (which depletes CoQ10), exercise, infections, and the aging process.,,,, CoQ10 deficiency is also a secondary effect of cholesterol-lowering statin drugs.,
People suffering from fatigue are often found to have low serum CoQ10 levels.,,,, Clinical studies suggest that CoQ10 supplementation may ameliorate fatigue associated with CFS, multiple sclerosis, and fibromyalgia.,, In healthy adults, CoQ10 has been shown to alleviate exercise-induced fatigue and improve physical performance.,,,
Supplemental CoQ10 may also be helpful for adults suffering from work-related fatigue. In a randomized, double-blind, placebo-controlled trial, nurses with significant work-related fatigue were randomly assigned to either 200 mg CoQ10 daily or a placebo. After four weeks of daily supplementation, a significant improvement in fatigue and sleep quality was found in the CoQ10 group as compared to the placebo group.
Nicotinamide adenine dinucleotide (NADH)
NADH and CoQ10, along with a membrane lipid formulation, significantly reduced fatigue in chronic Lyme disease patients.
Nicotinamide adenine dinucleotide (NADH) is a bioactive derivative of niacin (vitamin B3). Within the mitochondria, NADH serves an electron carrier for the ultimate production of ATP., It also serves as a cofactor for enzymes that recycle CoQ10, helping to keep CoQ10 in its active (ubiquinol) form., Cellular levels of both nicotinamide adenine dinucleotide and CoQ10 decline with age.,
Individuals with CFS often have low NADH levels., In studies of identical twins, where one of the twin pair was diagnosed with CFS and the other was not, the metabolism of NADH was closely associated with the development of fatigue.
In several clinical studies, individuals with CFS were asked to rate the extent to which fatigue had interfered with certain aspects of their day-to-day functioning.,, Those who took NADH (20 mg per day) along with CoQ10 (200 mg per day) reported improvements in physical functioning and mental clarity after eight weeks. The supplemented groups were found to have higher levels of ATP in their blood cells, and reported significantly less fatigue as compared to the placebo groups.,,
Mitochondrial dysfunction has also been seen in individuals with Lyme disease. In a pilot study, supplementation with NADH and CoQ10, along with a membrane lipid formulation, significantly reduced intractable fatigue in chronic Lyme disease patients.
Individuals receiving carnitine reported greater subjective energy levels compared to placebo groups.
Acetyl-L-carnitine is a short-chain ester of L-carnitine, an amino acid derivative that is naturally produced in the body and is also found in food. Various conditions may increase the body’s carnitine needs, leading to a shortfall in this nutrient.
Carnitine is indispensable for energy production, since it enables activated fatty acids to enter the mitochondria where they are broken down to form ATP.,, Low carnitine levels impair the transport of fatty acids into the mitochondria, thereby reducing energy production., In some groups of Lyme disease patients experiencing fatigue and inflammation, acyl carnitine levels were only one-third of healthy control levels.
In individuals with CFS, low blood and tissue carnitine levels often correlate with the presence of fatigue.,,, Studies suggest that carnitine supplementation may improve exercise performance in healthy adults, and it may alleviate fatigue in patients with CFS and other chronic conditions.,,,,,
Mitochondrial dysfunction is a major contributor to age-related muscle decline and fatigue., Fortunately, carnitine supplementation may be helpful for older adults with fatigue and/or frailty., Individuals receiving carnitine reported greater subjective energy levels compared to placebo groups.
Pyridoxal-5-phosphate (PLP) is a bioactive form of vitamin B6, a B-vitamin that serves as a cofactor for numerous biosynthetic enzymes. PLP is critical for the synthesis of heme, the oxygen-binding component of hemoglobin, which supplies oxygen to every tissue in the body.
An adequate supply of PLP is particularly important for muscle health and repair., PLP is needed for the synthesis of carnosine, a naturally occurring intramuscular dipeptide that is thought to attenuate fatigue during high-intensity exercise.,,
A study of patients with CFS found that levels of a PLP-dependent enzyme (AST) were only 60% of normal, suggesting an association between low vitamin B6 status and fatigue. Reduced levels of thiamine (vitamin B1)- and riboflavin (vitamin B2)-dependent enzymes were also seen, but to a lesser extent.
In older people, fatigue can make it difficult to carry out everyday chores, let alone exercise. A 2021 study of older adults found that higher intakes of vitamin B6 were associated with a better ability to rise out of a chair (a standard test of muscle strength and frailty). Also, greater B6 intakes were associated with improved handgrip strength in older adults with low physical activity levels.
Various studies have shown a positive association between magnesium status and muscle performance.
Magnesium is an essential mineral with many functions. It stabilizes mitochondrial membranes and serves as a cofactor for enzymes involved in ATP production., Importantly, magnesium plays a pivotal role in the activity of F1Fo-ATP synthase, the enzyme that produces the bulk of cellular ATP.,
A significant decline in serum magnesium concentrations has been seen in patients with CFS, multiple sclerosis, bacterial and viral infections, and many acute and chronic diseases.,,,,,
Patients with CFS who were supplemented with magnesium reported enhanced energy levels, a better emotional state, and less pain. Additionally, magnesium supplementation may alleviate muscle fatigue during exercise.,, Various studies have shown a positive association between magnesium status and muscle performance, including measures such as grip strength, lower-leg power, and jumping performance.,
Magnesium also assists in the activation of vitamin D, which is important for muscle strength and function., Supplemental magnesium and vitamin D may help reduce the risk of frailty as we age., (Note: To keep muscles strong during aging it’s also important to get enough dietary protein and physical activity!)
If you suffer from fatigue, be sure to consult a qualified health professional to rule out any underlying condition that might be causing the problem. Individuals who find that fatigue is interfering with their daily activities may want to consider supplementation with mitochondrial cofactors to see if they will help. Studies suggest that Coenzyme Q10, NADH, L-carnitine, pyridoxal phosphate and magnesium can improve mitochondrial function and reduce fatigue in many cases.Click here to see References
 Rosenthal TC, et al. Fatigue: an overview. Am Fam Physician. 2008 Nov 15;78(10):1173-9.
 Filler K, et al. Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clin. 2014 Jun 1;1:12-23.
 Keyser RE. Peripheral fatigue: high-energy phosphates and hydrogen ions. PM R. 2010 May;2(5):347-58.
 Picard M, McEwen BS. Psychological stress and mitochondria: a systematic review. Psychosom Med. Feb/Mar 2018;80(2):141-53.
 Lacourt TE, et al. The high costs of low-grade inflammation: persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure. Front Behav Neurosci. 2018 Apr 26;12:78.
 Morris G, et al. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med. 2015 Feb 6;13:28.
 Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne). 2020 Feb 25;7:57.
 Peacock BN, et al. New insights into Lyme disease. Redox Biol. 2015 Aug;5:66-70.
 Nicolson GL. Mitochondrial dysfunction and chronic disease: treatment with natural supplements. Altern Ther Health Med. 2014 Aug;13(4):35.
 Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953-9.
 Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. 2003 Feb;160(2):221-36.
 Yancey JR, Thomas SN. Chronic fatigue syndrome: diagnosis and treatment. Am Fam Physician. 2012 Oct 15;86(8):741-6.
 Myhill S, et al. Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) – a clinical audit. Int J Clin Exp Med. 2013;6(1):1-15.
 Sweetman E, et al. A SWATH-MS analysis of myalgic encephalomyelitis/chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020 Sep 24;18(1):365.
 Castro-Marrero J, et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013 Nov 20;19(15):1855-60.
 Tomas C, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017 Oct 24;12(10):e0186802.
 Bjørklund G, et al. Chronic fatigue syndrome (CFS): suggestions for a nutritional treatment in the therapeutic approach. Biomed Pharmacother. 2019 Jan;109:1000-7.
 Hernández-Camacho JD, et al. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018 Feb 5;9:44.
 Sarmiento et al. Coenzyme Q10 supplementation and exercise in healthy humans: a systematic review. Curr Drug Metab. 2016;17(4):345-58.
 Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014 Dec;2(6):641-9.
 Barbiroli B, et al. Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors. 1999;9(2-4):253-60.
 Garrido-Maraver J, et al. Coenzyme Q10 therapy. Mol Syndromol. 2014 Jul;5(3-4):187-97.
 Di Meo I, et al. Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med. 2015 Oct;7(10):1257-66.
 Niklowitz P, et al. Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration. J Clin Biochem Nutr. 2016 May;58(3):240-5.
 Chase M, et al. Coenzyme Q10 in acute influenza. Influenza Other Respir Viruses. 2019 Jan;13(1):64-70.
 Qu H, et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018 Oct 2;7(19):e009835.
 Langsjoen PH, et al. Statin-associated cardiomyopathy responds to statin withdrawal and administration of coenzyme Q10. Perm J. 2019;23:18-257.
 Parikh S, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015 Sep;17(9):689-701.
 Ciregia F, et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl Psychiatry. 2016 Sep 27;6(9):e904.
 Maes M, et al. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett. 2009;30(4):470-6.
 Fukuda S, et al. Ubiquinol‐10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors. 2016 Jul 8;42(4):431-40.
 Di Pierro F, et al. Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clin Exp Rheumatol. May-Jun 2017;35 Suppl 105(3):20-7.
 Sanoobar M, et al. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci. 2016;19(3):138-43.
 Gokbel H, et al. The effects of coenzyme Q10 supplementation on performance during repeated bouts of supramaximal exercise in sedentary men. J Strength Cond Res. 2010 Jan;24(1):97-102.
 Broome SC, et al. Mitochondria-targeted antioxidant supplementation improves 8 km time trial performance in middle-aged trained male cyclists. J Int Soc Sports Nutr. 2021 Aug 21;18(1):58.
 Suzuki Y, et al. Short-term ubiquinol-10 supplementation alleviates tissue damage in muscle and fatigue caused by strenuous exercise in male distance runners. Int J Vitam Nutr Res. 2021 Jun;91(3-4):261-70.
 Diaz-Castro J, et al. Beneficial effect of ubiquinol on hematological and inflammatory signaling during exercise. Nutrients. 2020 Feb 6;12(2):424.
 Mousavi S, et al. Effect of coenzyme Q10 supplementation on work-related fatigue in nurses: a double-blind, randomized placebo-controlled study. Fatigue: Biomedicine, Health & Behavior. 2020 Jan 2;8(1):1-10.
 Canto C, et al. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015 Jul 7;22(1):31-53.
 Covarrubias AJ, et al. NAD + metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021 Feb;22(2):119-41.
 Ross D, Siegel D. Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch. Front Physiol. 2017 Aug 24;8:595.
 Navas P, et al. The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion. 2007 Jun;7 Suppl:S34-40.
 Poljsak B, et al. Healthy lifestyle recommendations: do the beneficial effects originate from NAD + amount at the cellular level? Oxid Med Cell Longev. 2020 Dec 12;2020:8819627.
 Barcelos IP, Haas RH. CoQ10 and aging. Biology. 2019 Jun;8(2):28.
 Mikirova N, et al. The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission. Altern Ther Health Med. Jan-Feb 2012;18(1):36-40.
 Forsyth LM, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91.
 Ciregia F, et al. Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome. Transl Psychiatry. 2016 Sep 27;6(9):e904.
 Castro-Marrero J, et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015 Mar 10;22(8):679-85.
 Castro-Marrero J, et al. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome – A randomized, controlled, double-blind trial. Clin Nutr. 2016 Aug;35(4):826-34.
 Castro-Marrero J, et al. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Nutrients. 2021 Jul 30;13(8):2658.
 Fitzgerald BL, et al. Host metabolic response in early Lyme disease. J Proteome Res. 2020 Feb 7;19(2):610-23.
 Nicolson GL, et al. Glycophospholipid formulation with NADH and CoQ10 significantly reduces intractable fatigue in Western blot-positive ‘chronic Lyme disease’ patients: preliminary report. Funct Foods Health Dis. 2012 Mar 28;2(3):35-47.
 Fielding R, et al. L-Carnitine supplementation in recovery after exercise. Nutrients. 2018 Mar 13;10(3):349.
 Bremer J. Carnitine–metabolism and functions. Physiol Rev. 1983 Oct 1;63(4):1420-80.
 Chee C, et al. Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise. Aging Cell. 2021 Feb;20(2):e13303.
 Reuter SE, Evans AM. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet. 2012;51(9):553-72.
 Huang A, Owen K. Role of supplementary L-carnitine in exercise and exercise recovery. Med Sport Sci. 2012;59:135-42.
 Kępka A, et al. Serum carnitine concentration is decreased in patients with Lyme borreliosis. Postepy Hig Med Dosw (Online). 2016 Mar 4;70:180-5.
 Reuter SE, Evans AM. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J Intern Med. 2011 Jul;270(1):76-84.
 Kuratsune H, et al. Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage. 2002 Nov 1;17(3):1256-65.
 Malaguarnera M, et al. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr. 2008 Mar 1;46(2):181-90.
 Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology. 1995;32(3):132-8.
 Wall BT, et al. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol. 2011;589:963-73.
 Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl-and propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004 Mar 1;66(2):276-82.
 An JH, et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J. 2016 Oct 29;63(10):885-95.
 Ciacci C, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. Dig Liver Dis. 2007 Oct 1;39(10):922-8.
 Anty R, et al. Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome. Aliment Pharmacol Ther. 2011 Apr;33(8):961-8.
 Neri S, et al. L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology. 2003;47(2):94-7.
 Ringseis R, et al. Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies. Eur J Nutr. 2013 Aug;52(5):1421-42.
 Herpich C, et al. Age-related fatigue is associated with reduced mitochondrial function in peripheral blood mononuclear cells. Exp Gerontol. 2021 Feb;144:111177.
 Wawrzyniak NR, et al. Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle. Oncotarget. 2016;7:52695–709.
 Badrasawi M, et al. Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial. Clin Interv Aging. 2016;11:1675.
 Tardy AL, et al. Vitamins and minerals for energy, fatigue and cognition: a narrative review of the biochemical and clinical evidence. Nutrients. 2020 Jan;12(1):228.
 Hunter GA, Ferreira GC. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis. Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):102-10.
 Dhalla NS, et al. Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5-phosphate on cardiac performance in ischemic heart disease. Clin Chem Lab Med. 2013 Mar 1;51(3):535-43.
 Kumar A, et al. Metabolomic analysis of primary human skeletal muscle cells during myogenic progression. Sci Rep. 2020 Jul 16;10(1):11824.
 Suidasari S, et al. Carnosine content in skeletal muscle is dependent on vitamin B6 status in rats. Front Nutr. 2016 Jan 19;2:39.
 Begum G, et al. Physiological role of carnosine in contracting muscle. Int J Sport Nutr Exerc Metab. 2005 Oct;15(5):493-514.
 Varanoske AN, et al. Influence of skeletal muscle carnosine content on fatigue during repeated resistance exercise in recreationally active women. Nutrients. 2017 Sep 7;9(9):988.
 Heap LC, et al. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med. 1999 Apr;92(4):183-5.
 Azzolino D, et al. Nutritional status as a mediator of fatigue and its underlying mechanisms in older people. Nutrients. 2020 Feb 10;12(2):444.
 Grootswagers P, et al. Vitamin B-6 intake is related to physical performance in European older adults: results of the New Dietary Strategies Addressing the Specific Needs of the Elderly Population for Healthy Aging in Europe (NU-AGE) study. Am J Clin Nutr. 2021 Apr 6;113(4):781-9.
 Odai T, et al. Depressive symptoms in middle-aged and elderly women are associated with a low intake of vitamin B6: a cross-sectional study. Nutrients. 2020 Nov 9;12(11):3437.
 Kafeshani M, et al. Higher vitamin B6 intake is associated with lower depression and anxiety risk in women but not in men: a large cross-sectional study. Int J Vitam Nutr Res. 2020 Oct;90(5-6):484-92.
 Golshani-Hebroni S. Mg(++) requirement for MtHK binding, and Mg(++) stabilization of mitochondrial membranes via activation of MtHK & MtCK and promotion of mitochondrial permeability transition pore closure: a hypothesis on mechanisms underlying Mg(++)’s antioxidant and cytoprotective effects. Gene. 2016 Apr 25;581(1):1-13.
 Yamanaka R, et al. Mitochondrial Mg 2+ homeostasis decides cellular energy metabolism and vulnerability to stress. Sci Rep. 2016 Jul 26;6(1):1-2.
 Ko YH, et al. Chemical mechanism of ATP synthase. Magnesium plays a pivotal role in formation of the transition state where ATP is synthesized from ADP and inorganic phosphate. J Biol Chem. 1999 Oct 8;274(41):28853-6.
 Syroeshkin AV, et al. Kinetic mechanism of Fo x F1 mitochondrial ATPase: Mg2+ requirement for Mg x ATP hydrolysis. Biochemistry (Mosc). 1999 Oct;64(10):1128-37.
 Cojocaru IM, et al. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections. Rom J Intern Med. 2009 Jan 1;47(2):169-71.
 Fiorentini D, et al. Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients. 2021 Mar 30;13(4):1136.
 Bitarafan S, et al. Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients. Iran J Neurol. 2014;13(1):28-32.
 Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001 Feb;56(2):163-70.
 Kolte D, et al. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014 Jul 1;22(4):182-92.
 Dominguez LJ, et al. Magnesium in infectious diseases in older people. Nutrients. 2021 Jan 8;13(1):180.
 Cox IM, et al. Red blood cell magnesium and chronic fatigue syndrome. Lancet. 1991 Mar 30;337(8744):757-60.
 Reno AM, et al. Effects of magnesium supplementation on muscle soreness and performance. J Strength Cond Res. 2020 Oct 1. doi: 10.1519/JSC.0000000000003827.
 Zhang Y, et al. Can magnesium enhance exercise performance?. Nutrients. 2017 Sep;9(9):946.
 Tanabe K, et al. Efficacy of oral magnesium administration on decreased exercise tolerance in a state of chronic sleep deprivation. Jpn Circ J. 1998 May;62(5):341-6.
 Cameron D, et al. Age and muscle function are more closely associated with intracellular magnesium, as assessed by 31 P magnetic resonance spectroscopy, than with serum magnesium. Front Physiol. 2019 Nov 27;10:1454.
 Dominguez LJ, et al. Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr. 2006 Aug;84(2):419-26.
 Veronese N, et al. Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: a randomized controlled trial. Am J Clin Nutr. 2014 Sep 1;100(3):974-81.
 Uwitonze AM, Razzaque MS. Role of magnesium in vitamin D activation and function. J Am Osteopath Assoc. 2018 Mar 1;118(3):181-9.
 Rosanoff A, et al. Essential nutrient interactions: does low or suboptimal magnesium status interact with vitamin D and/or calcium status? Adv Nutr. 2016 Jan 15;7(1):25-43.
 Kheyruri F, et al. Randomized study of the effects of vitamin D and magnesium co-supplementation on muscle strength and function, body composition, and inflammation in vitamin D-deficient middle-aged women. Biol Trace Elem Res. 2021 Jul;199(7):2523-34.
 Welch AA, et al. Dietary magnesium may be protective for aging of bone and skeletal muscle in middle and younger older age men and women: cross-sectional findings from the UK Biobank Cohort. Nutrients. 2017 Oct 30;9(11):1189.